Financial regulation

China Life Insurance Company Limited Change of President

Retrieved on: 
星期五, 八月 4, 2023

BEIJING, Aug. 4, 2023 /PRNewswire/ -- China Life Insurance Company Limited (the "Company") (NYSE: LFC; SSE: 601628; HKSE: 2628) announced today that due to the adjustment of work arrangements, Mr. Zhao Peng tendered his resignation as the President, an Executive Director and a member of the Strategy and Assets and Liabilities Management Committee of the Company on August 4, 2023, which took effect on the same day.

Key Points: 
  • BEIJING, Aug. 4, 2023 /PRNewswire/ -- China Life Insurance Company Limited (the "Company") (NYSE: LFC; SSE: 601628; HKSE: 2628) announced today that due to the adjustment of work arrangements, Mr. Zhao Peng tendered his resignation as the President, an Executive Director and a member of the Strategy and Assets and Liabilities Management Committee of the Company on August 4, 2023, which took effect on the same day.
  • The Company would like to express its gratitude to Mr. Zhao Peng for his contribution to the Company during his tenure of service.
  • The Company further announced that at the twenty-seventh meeting of the seventh session of the Board of the Company held on August 4, 2023, Mr. Li Mingguang has been appointed as the President of the Company and his qualification as the President of the Company is subject to the approval of the National Administration of Financial Regulation.
  • He was the Chief Actuary of China Life Pension Company Limited and a Director of China Life Asset Management Company Limited.

SEC Names Natasha Vij Greiner and Keith E. Cassidy Interim Acting Co-Directors of the Division of Examinations

Retrieved on: 
星期二, 七月 25, 2023

Washington, D.C.--(Newsfile Corp. - July 25, 2023) - The Securities and Exchange Commission today announced that Natasha Vij Greiner and Keith E. Cassidy have been named interim Acting Co-Directors of the Division of Examinations, effective immediately, while Division Director Richard Best is on extended medical leave from the agency.

Key Points: 
  • Washington, D.C.--(Newsfile Corp. - July 25, 2023) - The Securities and Exchange Commission today announced that Natasha Vij Greiner and Keith E. Cassidy have been named interim Acting Co-Directors of the Division of Examinations, effective immediately, while Division Director Richard Best is on extended medical leave from the agency.
  • “My thoughts are with Rich as he’s away from the agency on medical leave,” said SEC Chair Gary Gensler.
  • “I thank Natasha and Keith for stepping in on an interim basis to lead the Division of Examinations.
  • Ms. Greiner and Mr. Cassidy will continue to serve in their current leadership roles within the Division.

SEC Charges Florida Resident for Operating $112 Million Ponzi Scheme that Targeted Haitian-American Community

Retrieved on: 
星期一, 六月 26, 2023

As alleged, Singh and Royal Bengal promised investors the company would use their money to expand operations and increase its fleet of semi-trucks and trailers.

Key Points: 
  • As alleged, Singh and Royal Bengal promised investors the company would use their money to expand operations and increase its fleet of semi-trucks and trailers.
  • According to the SEC’s complaint, defendants assured investors that these investment programs were safe, and that Royal Bengal generated up to $1 million in revenue per month.
  • In reality, the SEC alleges, Royal Bengal has operated at a loss and used approximately $70 million of new investor funds to make Ponzi-like payments to other investors.
  • “As alleged in our complaint, Singh targeted many members of the Haitian-American community to raise money in a Ponzi-like scheme to enrich himself,” said Eric I. Bustillo, Director of the SEC’s Miami Regional Office.

Bragar Eagel & Squire, P.C. Is Investigating Fox, Provident, UP Fintech, and G-III and Encourages Investors to Contact the Firm

Retrieved on: 
星期二, 六月 20, 2023

Our investigations concern whether these companies have violated the federal securities laws and/or engaged in other unlawful business practices.

Key Points: 
  • Our investigations concern whether these companies have violated the federal securities laws and/or engaged in other unlawful business practices.
  • Additional information about each case can be found at the link provided.
  • In the wake of the 2020 U.S. Presidential Election, Dominion Voting Systems sued Fox for defamation.
  • On this news, Provident's stock price fell $2.20, or 21%, to close at $7.90 on November 16, 2022, on unusually high trading volume.

RevoluGROUP Canada Inc. Provides Corporate Update

Retrieved on: 
星期一, 六月 12, 2023

Vancouver, BC, June 12, 2023 (GLOBE NEWSWIRE) -- RevoluGROUP Canada Inc. (TSX-V: REVO ), (Frankfurt: IJA2 ), (Munich: A2PU92 ), (the "Company") is pleased to announce a corporate update.

Key Points: 
  • Vancouver, BC, June 12, 2023 (GLOBE NEWSWIRE) -- RevoluGROUP Canada Inc. (TSX-V: REVO ), (Frankfurt: IJA2 ), (Munich: A2PU92 ), (the "Company") is pleased to announce a corporate update.
  • Corporate compliance has approved the LRC segregated accounts, and management awaits the final countersigned agreement this week.
  • The Company is pleased to announce that the annual RevoluGROUP USA Inc. audit has concluded successfully.
  • The Company expects to update shareholders shortly concerning Andorran-focused positive developments due to Mr. Marshall's meetings.

Ambrx Appoints Jared Kelly as General Counsel

Retrieved on: 
星期一, 六月 5, 2023

SAN DIEGO, June 05, 2023 (GLOBE NEWSWIRE) -- Ambrx Biopharma Inc., or Ambrx (NASDAQ: AMAM), today announced the appointment of Jared Kelly as Senior Vice President, General Counsel and Corporate Secretary.

Key Points: 
  • SAN DIEGO, June 05, 2023 (GLOBE NEWSWIRE) -- Ambrx Biopharma Inc., or Ambrx (NASDAQ: AMAM), today announced the appointment of Jared Kelly as Senior Vice President, General Counsel and Corporate Secretary.
  • After practicing for more than ten years at large corporate law firms, Mr. Kelly brings his extensive experience advising public companies on corporate governance, financing transactions and mergers and acquisitions to Ambrx.
  • “Ambrx welcomes Jared Kelly, whose wealth of experience as a member of world-leading law firms representing public companies in corporate and securities law, particularly in the biotech sector, makes him a tremendous asset to our team,” said Daniel J. O’Connor, Chief Executive Officer of Ambrx.
  • The Company approved the award as an inducement material to Mr. Kelly entering into employment with the Company in accordance with NASDAQ Listing Rule 5635(c)(4).

Bragar Eagel & Squire, P.C. Is Investigating UP Fintech, Shift4, and TriplePoint and Encourages Investors to Contact the Firm

Retrieved on: 
星期六, 五月 20, 2023

Our investigations concern whether these companies have violated the federal securities laws and/or engaged in other unlawful business practices.

Key Points: 
  • Our investigations concern whether these companies have violated the federal securities laws and/or engaged in other unlawful business practices.
  • Additional information about each case can be found at the link provided.
  • TriplePoint is the subject of a report issued by the Bear Cave on May 2, 2023.
  • For more information on the TriplePoint investigation go to: https://bespc.com/cases/TPVG

Highlights - Public Hearing on conflicts of interests in the management of EU funds - Committee on Budgetary Control

Retrieved on: 
星期三, 五月 17, 2023

Public Hearing on conflicts of interests in the management of EU funds

Key Points: 
  • Public Hearing on conflicts of interests in the management of EU funds
    17-05-2023 - 16:17
    On 24 May 2023, the Committee on Budgetary Control (CONT) will hold a public hearing on the application of the rules on conflicts of interests in the management of EU funds in the Member States.
  • Two years after the adoption of the European Commission's guidance on the avoidance and management of conflicts of interests under the Financial Regulation, what are the experiences of Member States in avoiding and managing conflicts of interests based on EU financial rules?
  • The CONT Committee will hear the views from regional managing authorities, from the Romanian National integrity Agency and from the European Commission and discuss lessons learned linked to the application of the rules on conflicts of interests in relation to the management of EU funds in the Member States.

Nefecon Included in the Reimbursement Drug List of "Beijing Puhui Health Insurance Program" as a First-in-Disease Therapy for IgA Nephropathy

Retrieved on: 
星期五, 五月 12, 2023

SHANGHAI, May 11, 2023 /PRNewswire/ -- An imported version of Nefecon (budesonide) delayed release capsule has been added to the 2023 New Reimbursement Drug List of Specialized Medicines of the "Beijing Puhui Health Insurance Program.

Key Points: 
  • SHANGHAI, May 11, 2023 /PRNewswire/ -- An imported version of Nefecon (budesonide) delayed release capsule has been added to the 2023 New Reimbursement Drug List of Specialized Medicines of the "Beijing Puhui Health Insurance Program.
  • Coverage by this and other local insurance plans will help increase patient access to Nefecon, listed in the Beijing Puhui Health Insurance Program as "TARPEYO."
  • "The inclusion of Nefecon into the drug reimbursement list of the Beijing Puhui Health Insurance Program enables patients insured in Beijing to receive reimbursement for up to 60% of the drug costs.
  • In addition to Beijing, Nefecon has also been included in other local insurance programs, such as those in Kunming city and Shanxi Province.